Glihypo-Plus 20 Tablet
Marketer
AN Pharmaceuticals Pvt Ltd
Salt Composition
Rosuvastatin (20mg)
Overview Glihypo-Plus 20 Tablet
Cholesto-Stat 20mg tablets are statin medications used to lower cholesterol and lessen the risk of cardiovascular events. High cholesterol, a fatty substance accumulating in blood vessels, causes narrowing that can result in heart attacks or strokes. Cholesto-Stat 20mg is a commonly prescribed, generally safe medication for long-term use, taken with or without food at any time of day, but consistently at the same time daily. While high cholesterol often presents without symptoms, discontinuing treatment can elevate cholesterol, worsening the condition and increasing heart disease/stroke risk. Regular cholesterol monitoring is essential. This medication is part of a comprehensive program including diet, exercise, smoking cessation, moderate alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Common, usually mild and transient side effects include muscle aches, weakness, nausea, headache, and stomach upset. Persistent symptoms, jaundice, or recurring/unexplained muscle pain warrant medical attention. Contraindicated in liver disease, pregnancy, and breastfeeding due to potential fetal harm. Diabetics should monitor blood sugar levels as this medication may elevate them.
Uses of Glihypo-Plus 20 Tablet
Managing elevated cholesterol levels to reduce the risk of cardiovascular events such as heart attack and stroke.
Major Benefits of Glihypo-Plus 20 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glihypo-Plus 20 Tablets can be consumed with or without food, although consistent timing is recommended for optimal results.
Common Side effects of Glihypo-Plus 20 Tablet:
- Muscle pain
- Weakness
- Headache
- Abdominal pain
- Dizziness
- Joint pain
- Nausea
How to use Glihypo-Plus 20 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Glihypo-Plus 20 Tablet can be consumed with or without food, though consistent timing is recommended.
How Glihypo-Plus 20 Tablet works:
Lipitor 20mg tablets reduce cholesterol levels. This statin medication inhibits HMG-CoA reductase, an enzyme vital for cholesterol production. Consequently, it decreases LDL ("bad") cholesterol and triglycerides while increasing HDL ("good") cholesterol.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Glihypo-Plus 20 Tablet and alcohol. Seek medical advice before doing so.
PregnancyUNSAFE
The use of Glihypo-Plus 20 Tablets is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in both animal and human studies has revealed substantial risks to the fetus.
Breast feedingUNSAFE
The use of Glihypo-Plus 20 Tablet while breastfeeding is contraindicated. Evidence indicates potential harm to the infant.
DrivingSAFE
Driving ability is typically unaffected by Glihypo-Plus 20 Tablet.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Glihypo-Plus 20 Tablets, as dosage modification may be necessary. Consultation with a physician is advised. Glihypo-Plus 20 Tablets are contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Exercise caution when prescribing Glihypo-Plus 20 Tablet to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glihypo-Plus 20 Tablet is contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Glihypo-Plus 20 Tablet :
Should you forget a Glihypo-Plus 20 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking two doses within a 12-hour period.
Facts to Know About Glihypo-Plus 20 Tablet
| Label | Value |
|---|---|
| Type of Compound | Compounds based on the phenylpyrimidine scaffold |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |






